-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Assumes Immunocore Holdings at Neutral

Benzinga·09/18/2025 13:26:37
Listen to the news
Guggenheim analyst Paul Jeng assumes Immunocore Holdings (NASDAQ:IMCR) with a Neutral rating.